Exclusive

Publication

Byline

Oil under pressure as US blockade of Hormuz beginsPublished on: April 14, 2026 9:58 AM

Pakistan, April 14 -- The United States Naval blockade begins in the Strait of Hormuz after the deadline of 7 pm (10 am ET). A blockade was imposed on all the ships entering or leaving Iranian ports. ... Read More


वैभव सूर्यवंशी एक और इतिहास रचने के करीब, आयरलैंड दौरे के लिए हुए शॉर्टलिस्ट

नई दिल्ली, अप्रैल 14 -- क्रिकेट सनसनी वैभव सूर्यवंशी अपनी विस्फोटक पारियों से खेलप्रेमियों का खूब मनोरंजन कर रहे हैं। राजस्थान रॉयल्स के पांचवें मैच को छोड़ दें तो आईपीएल 2026 में उनका बल्ला खूब गरज र... Read More


NSE का Rs.20000 करोड़ का IPO कब आ रहा है, कौन खरीद पाएगा शेयर और कौन बेचेगा?

नई दिल्ली, अप्रैल 14 -- नेशनल स्टॉक एक्सचेंज (NSE) के IPO का लंबे समय से इंतजार हो रहा है। एनएसई भी सेबी के पास अपने IPO के ड्राफ्ट पेपर दाखिल करने की तैयारी में है। मीडिया रिपोर्ट्स के अनुसार, इस IPO... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate ... Read More


Singapore Clinical Trial: A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safet... Read More


Singapore Clinical Trial: Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients'. The... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy... Read More


Singapore Clinical Trial: Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome

Singapore, April 14 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'... Read More